O106 A CHEMORADIOTHERAPY TREATMENT RESPONSE MRNA SIGNATURE AS PREDICTOR FOR ESOPHAGEAL ADENOCARCINOMA TREATED ACCORDING TO THE CROSS REGIMEN. (23rd November 2019) - Hoefnagel, S J M